Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Dainippon Sumitomo Pharma: PharmaVitae Profile' returned 8 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Profile   Datamonitor, April 2009, Pages: 98 , 2001-07 Figure 29: Return on capital employed formula Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Profile Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Model   Datamonitor, Jan 2009 financial statements and pipeline data Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Model Daiichi Sankyo Co., Ltd: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 59 Chugai Pharmaceutical Co. Ltd CuraGen Corporation Daiichi Sankyo, Ltd. Dainippon Sumitomo Pharma Co., Ltd. Eli Lilly and Company Forest Laboratories, Inc IMS Health Merck & Co., Inc. Novartis AG Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile   Datamonitor, June 2010, Pages: 64 portfolio Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Executive summary Quarterly update Company introduction Company sales Company financials Key products Eisai Co., Ltd: PharmaVitae Profile   Datamonitor, Jan 2011, Pages: 76 Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Chapter 2 Executive summary Key findings Prescription pharmaceutical sales and growth rate performance Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile   Datamonitor, Oct 2010, Pages: 98 - Investigate the diverse strategies being employed by Japan's oldest and largest pharmaceutical player Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Chapter Product Profiles: Marketed Antibacterials - Increasing genericization and fragmentation shape a crowded market   Datamonitor, Nov 2011, Pages: 110 Clinical and commercial attractiveness Merrem/Meropen (meropenem; AstraZeneca/Dainippon Sumitomo Pharma) Drug profile Development overview SWOT analysis Product positioning Astellas Pharma Inc.: PharmaVitae Profile   Datamonitor, Oct 2010, Pages: 95 and, going forward, for the Japanese drugmaker to become a leading player in the overactive bladder space. Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network